HLB Therapeutics Co.,Ltd. (115450.KQ)
KRW 10680.0
(-2.11%)
KRW 10680.0
(-2.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.32 Billion | -8.8 Billion | -11.26 Billion | -11.65 Billion | -5.54 Billion | -3.52 Billion |
| Net Income | -1.99 Billion | -10.82 Billion | -17.19 Billion | -16.9 Billion | -16.01 Billion | 4.57 Billion |
| Depreciation & Amortization | 8.47 Billion | 1.66 Billion | 1.7 Billion | 688.12 Million | 670.25 Million | 332.87 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 213.52 Million | -83.88 Million | 153.27 Million | 471.16 Million | 370.38 Million | - |
| Change in working capital | 4.55 Billion | -3.28 Billion | -1.09 Billion | -2.9 Billion | 1.97 Billion | -2.25 Billion |
| Other non-cash items | 7.88 Billion | 7.18 Billion | 11.08 Billion | 12.36 Billion | 7.13 Billion | -3.31 Billion |
| Investing Cash Flow | -20.15 Billion | -41.93 Billion | 14.35 Billion | -17.58 Billion | -15.68 Billion | -4.54 Billion |
| Investments in PPE | -5.75 Billion | -5.58 Billion | -3.93 Billion | -8.06 Billion | -10.72 Billion | -1.74 Billion |
| Acquisitions | 2.59 Billion | 216.25 Million | 40.9 Million | 66.44 Million | 341.09 Million | -1.3 Billion |
| Investment purchases | -108.59 Billion | -123.38 Billion | -89.99 Million | -17.19 Billion | -20.85 Billion | -10.75 Million |
| Sales/Maturities of investments | 84.45 Billion | 93.01 Billion | 18.96 Billion | 7.39 Billion | 15.94 Billion | 300 Million |
| Other Investing Activities | 7.13 Billion | -6.18 Billion | -627.49 Million | 215.78 Million | -387.42 Million | -1.78 Billion |
| Financing Cash Flow | -5.28 Billion | -3.31 Billion | 82.85 Billion | -32.42 Million | 47.75 Billion | 19.3 Billion |
| Debt repayment | -11.07 Billion | -2.54 Billion | -43.99 Billion | -141.63 Million | -46.79 Billion | -9.41 Billion |
| Dividends payments | - | - | - | - | -46.56 Million | - |
| Common Stock Repurchased | -70.11 Million | - | - | - | - | - |
| Common Stock Issuance | 13 Billion | -7.07 Million | 40 Billion | 34.58 Million | 1.24 Billion | 9.92 Billion |
| Other Financing Activities | -14.59 Million | -7.07 Million | -10.00 | 34.58 Million | -46.56 Million | -24.25 Million |
| Accounts receivables | -956.2 Million | 2.08 Billion | -1.64 Billion | 2.86 Billion | 4.27 Billion | -6.49 Billion |
| Accounts payables | 951.82 Million | 605.9 Million | -1.6 Billion | -6.45 Billion | -3.02 Billion | -632.8 Million |
| Inventory | 1.35 Billion | -2.9 Billion | 891.61 Million | 74 Million | 781.55 Million | 4.92 Billion |
| Other working capital | 3.2 Billion | -3.05 Billion | 1.25 Billion | 618.31 Million | -50.38 Million | -47.62 Million |
| Cash at beginning of period | 45.82 Billion | 99.87 Billion | 13.93 Billion | 43.19 Billion | 16.65 Billion | 5.4 Billion |
| Cash at end of period | 23.7 Billion | 45.82 Billion | 99.87 Billion | 13.93 Billion | 43.19 Billion | 16.65 Billion |
| Capital Expenditure | -5.75 Billion | -5.58 Billion | -3.93 Billion | -8.06 Billion | -10.72 Billion | -1.74 Billion |
| Effect of forex changes on cash | 1.6 Million | 4.97 Million | 3.85 Million | -4.29 Million | 16.28 Million | - |
| Net cash flow / Change in cash | -22.11 Billion | -54.05 Billion | 85.94 Billion | -29.26 Billion | 26.54 Billion | 11.24 Billion |
| Free Cash Flow | -2.43 Billion | -14.39 Billion | -15.2 Billion | -19.72 Billion | -16.27 Billion | -5.26 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.26 Billion | 159.55 Million | -1.99 Billion | -3.96 Billion | -1.12 Billion | 3.24 Billion |
| Depreciation & Amortization | 1.85 Billion | 2.08 Billion | 8.47 Billion | 2.04 Billion | 2.16 Billion | 3.92 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 190.03 Million | 130.37 Million | 213.52 Million | 136.78 Million | 76.74 Million | - |
| Change in working capital | -6.99 Billion | 383.4 Million | 4.55 Billion | 11.95 Billion | -3.98 Billion | -20.52 Billion |
| Other non-cash items | 18.88 Billion | 609.89 Million | 7.88 Billion | -2.84 Billion | 6.3 Billion | 7.64 Billion |
| Investing Cash Flow | -23.39 Billion | -3.41 Billion | -20.15 Billion | 13.09 Billion | -1.76 Billion | -3.12 Billion |
| Investments in PPE | 120.07 Million | -2.15 Billion | -5.75 Billion | -1.67 Billion | -1.49 Billion | -195.51 Million |
| Acquisitions | -3.01 Million | 25 Million | 2.59 Billion | -5.78 Billion | 10.31 Billion | -1.93 Billion |
| Investment purchases | -26.03 Billion | -7.83 Billion | -108.59 Billion | -7.06 Billion | -40.69 Billion | -35.17 Billion |
| Sales/Maturities of investments | 4.13 Billion | 7 Billion | 84.45 Billion | 19.72 Billion | 30.25 Billion | 34.45 Billion |
| Other Investing Activities | -23.51 Billion | -454.07 Million | 7.13 Billion | 7.89 Billion | -149.75 Million | -278.78 Million |
| Financing Cash Flow | 27.86 Billion | -1.66 Billion | -5.28 Billion | -5.77 Billion | -7.33 Billion | 9.57 Billion |
| Debt repayment | -2.01 Billion | -1.74 Billion | -11.07 Billion | -4 Billion | -5.43 Billion | -1.58 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -192.73 Million | - | -70.11 Million | 10.00 | - | -55.52 Million |
| Common Stock Issuance | 10.07 Billion | 73.53 Million | 13 Billion | - | - | 13 Billion |
| Other Financing Activities | 30.07 Billion | -15.68 Million | -14.59 Million | -20.00 | -7.33 Billion | 10.00 |
| Accounts receivables | 14.8 Million | 2.56 Billion | -956.2 Million | 11.64 Billion | -10.34 Billion | -2.79 Billion |
| Accounts payables | -1.08 Billion | -324.6 Million | 951.82 Million | -4.31 Billion | 6.36 Billion | -1.77 Billion |
| Inventory | -635.89 Million | -288.7 Million | 1.35 Billion | 328.82 Million | -1.18 Billion | 1.62 Billion |
| Other working capital | -6.37 Billion | -1.57 Billion | 3.2 Billion | 4.43 Billion | 1.04 Billion | -17.58 Billion |
| Cash at beginning of period | 19.65 Billion | 23.7 Billion | 45.82 Billion | 5.62 Billion | 20.85 Billion | 30.87 Billion |
| Cash at end of period | 15.82 Billion | 19.65 Billion | 23.7 Billion | 23.7 Billion | 5.62 Billion | 20.85 Billion |
| Capital Expenditure | 120.07 Million | -2.15 Billion | -5.75 Billion | -1.67 Billion | -1.49 Billion | -195.51 Million |
| Effect of forex changes on cash | 30.33 Million | 8.94 Million | 1.6 Million | -917.28 Thousand | 3.7 Million | 37.76 Million |
| Net cash flow / Change in cash | -3.83 Billion | -4.05 Billion | -22.11 Billion | 18.08 Billion | -15.23 Billion | -10.01 Billion |
| Free Cash Flow | -8.2 Billion | -1.13 Billion | -2.43 Billion | 9.09 Billion | -7.63 Billion | -16.69 Billion |
RIAS-B
AGN
TREEHOUSE
6262
9997
ENX